|1.||Takanashi, Hisanori: 4 articles (08/2009 - 03/2008)|
|2.||Sanger, Gareth J: 3 articles (01/2016 - 01/2013)|
|3.||Muramatsu, Hiroyasu: 3 articles (08/2009 - 03/2008)|
|4.||Yogo, Kenji: 3 articles (08/2009 - 03/2008)|
|5.||Ozaki, Ken-ichi: 3 articles (08/2009 - 03/2008)|
|6.||Cynshi, Osamu: 3 articles (08/2009 - 03/2008)|
|7.||Onoma, Mitsu: 3 articles (08/2009 - 03/2008)|
|8.||Kamei, Kenshi: 3 articles (08/2009 - 03/2008)|
|9.||Mack, R J: 3 articles (04/2002 - 12/2000)|
|10.||Broad, John: 2 articles (09/2013 - 01/2013)|
01/01/2016 - "In clinical trials, the motilin receptor agonist camicinal increased gastric emptying, but at lower doses reduced gastroparesis symptoms and improved appetite. "
07/01/2008 - "Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis."
04/28/2000 - "The gastroprokinetic effects of de(N-methyl)-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal (EM574), a non-peptide motilin receptor agonist, were investigated in conscious dogs in a normal state and with experimentally-induced gastroparesis. "
09/01/1990 - "The authors mention also their experience in the treatment of severe diabetic gastroparesis with erythromycin, agonist of the gastric and duodenal motilin receptors. "
09/05/2013 - "Nevertheless, more selective 5-HT4 and motilin receptor agonists (erythromycin, directly stimulating gastric motility) inhibit vomiting in animals; low doses of erythromycin can also relieve symptoms in patients with gastroparesis. "
|2.||Gastroesophageal Reflux (GERD)
12/01/2000 - "Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial."
12/01/2000 - "Motilin-receptor agonists are prokinetics; whether they relieve the symptoms of functional dyspepsia is unknown. "
06/05/2009 - "Since ABT-229 (a first generation of motilin receptor agonist) had failed to demonstrate symptomatic relief in functional dyspepsia and diabetic gastroparesis, there is a controversy for which of prokinetics or relaxants is clinically beneficial. "
|4.||Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
|5.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)